are glp 1 considered specialty drugs GLP-1 medications get at the heart of addiction: study – WashU Medicine Specialty pharmacy partnership improves access
Description
Acknowledgments The authors thank the participants of the FIH study

[DOI] [PubMed] [Google Scholar] 63.Sedeo-Diaz J., Ruiz-Serrato A., Vallejo-Herrera M.J., Villar-Jimenez J., Gomez-Lora D., Garcia-Ordoez M.A

Ro empowers patients to connect with a licensed provider and, if appropriate, determine which GLP-1 is the best option based on their insurance coverage, the cost, and their unique clinical needs and health goals whether they're just getting started or in search of a maintenance option

company announced the result of its SRUMOUNT study conducted on obese patients with a BMI of 30kg/ or more or those with BMI of 27kg/ or more having one or more weight-related comorbidities

Current as of 6/18/26 Are there any clinical criteria for approval (e.g., BMI level, sustained weight min/max, step therapy such as a weight loss management program)

These updated warnings include further advice for patients using oral contraceptives: Patients taking tirzepatide are advised to switch to a non-oral contraceptive or add a barrier method of contraception for 4 weeks after first taking the medicine and for 4 weeks after each increase in the dose
